BlackRock Inc. decreased its stake in Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) by 2.9% in the third quarter, HoldingsChannel reports. The firm owned 13,565,624 shares of the company’s stock after selling 406,434 shares during the period. BlackRock Inc. owned 0.16% of Pediatrix Medical Group worth $223,971,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Eagle Bay Advisors LLC boosted its holdings in shares of Pediatrix Medical Group by 122.5% in the second quarter. Eagle Bay Advisors LLC now owns 1,595 shares of the company’s stock worth $34,000 after buying an additional 878 shares during the period. Bank of America Corp DE boosted its stake in Pediatrix Medical Group by 0.3% in the 1st quarter. Bank of America Corp DE now owns 278,204 shares of the company’s stock worth $6,532,000 after purchasing an additional 933 shares during the period. Cubist Systematic Strategies LLC grew its position in Pediatrix Medical Group by 3.9% during the 3rd quarter. Cubist Systematic Strategies LLC now owns 26,562 shares of the company’s stock worth $439,000 after purchasing an additional 1,008 shares in the last quarter. MetLife Investment Management LLC raised its stake in Pediatrix Medical Group by 2.4% during the 3rd quarter. MetLife Investment Management LLC now owns 45,151 shares of the company’s stock valued at $745,000 after purchasing an additional 1,040 shares during the period. Finally, Royal Bank of Canada lifted its holdings in shares of Pediatrix Medical Group by 97.3% in the third quarter. Royal Bank of Canada now owns 2,166 shares of the company’s stock valued at $35,000 after purchasing an additional 1,068 shares in the last quarter. Hedge funds and other institutional investors own 95.99% of the company’s stock.
Analyst Ratings Changes
Several research analysts recently weighed in on MD shares. Mizuho dropped their price target on Pediatrix Medical Group from $21.00 to $17.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 16th. Credit Suisse Group dropped their target price on Pediatrix Medical Group from $27.00 to $23.00 and set an “outperform” rating on the stock in a report on Wednesday, February 22nd. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $19.00.
Pediatrix Medical Group Stock Performance
About Pediatrix Medical Group
Pediatrix Medical Group, Inc engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.
- Get a free copy of the StockNews.com research report on Pediatrix Medical Group (MD)
- First Republic: First Rate Risk or Time To Buy?
- These Hedge Funds Are Getting Crushed By SVB
- Buy The Dip In The Charles Schwab Corporation
- ZIM Integrated Shipping Services: Up 15% But Don’t Chase It
- FedEx Is A Buy Going Into Earnings
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating).
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.